OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastoma
Daniel J. Laverty, Shiv K. Gupta, Gary A. Bradshaw, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Daniel J. Laverty, Shiv K. Gupta, Gary A. Bradshaw, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Showing 7 citing articles:
Transcriptomic Analysis Divulges Differential Expressions of Microglial Genes After Microglial Repopulation in Mice
Muhammad Hafeez, Hao Gao, Furong Ju, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1494-1494
Open Access
Muhammad Hafeez, Hao Gao, Furong Ju, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1494-1494
Open Access
Loss of JAK1 Function Causes G2/M Cell Cycle Defects Vulnerable to Kif18a Inhibition
Vanessa Kelley, Marta Baro, William Gasperi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Vanessa Kelley, Marta Baro, William Gasperi, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
The Development of ATM Inhibitors in Cancer Therapy
Elizabeth A. Ampolini, Judit Jiménez-Sáinz, David T. Long
Targeted Oncology (2025)
Open Access
Elizabeth A. Ampolini, Judit Jiménez-Sáinz, David T. Long
Targeted Oncology (2025)
Open Access
Advancing Glioblastoma Therapy: Learning From the Past and Innovations for the Future
Mandeep Rana, Ke-Chi Liou, Amandeep Thakur, et al.
Cancer Letters (2025), pp. 217601-217601
Closed Access
Mandeep Rana, Ke-Chi Liou, Amandeep Thakur, et al.
Cancer Letters (2025), pp. 217601-217601
Closed Access
MAGL targeted PROTAC degrader simultaneously enhances P53 for synergistic treatment of glioblastoma stem cell
Zheng Yuan, Meixia Guo, Yue Zhang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Zheng Yuan, Meixia Guo, Yue Zhang, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Medicinal chemistry breakthroughs on ATM, ATR, and DNA-PK inhibitors as prospective cancer therapeutics
Ram Lal Sharma, Anshul Mishra, Monika Bhardwaj, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Ram Lal Sharma, Anshul Mishra, Monika Bhardwaj, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2025) Vol. 40, Iss. 1
Open Access
Targeting mesenchymal monocyte-derived macrophages to enhance the sensitivity of glioblastoma to temozolomide by inhibiting TNF/CELSR2/p65/Kla-HDAC1/EPAS1 axis
Wei Gao, Xinmiao Long, Xiang Lin, et al.
Journal of Advanced Research (2025)
Open Access
Wei Gao, Xinmiao Long, Xiang Lin, et al.
Journal of Advanced Research (2025)
Open Access
Relevance of Small Molecule Inhibitors in Advancing Cancer Therapeutics
Meltem Kaya, Gamze Tuna, Selda Yılmaz
(2024), pp. 103-117
Closed Access
Meltem Kaya, Gamze Tuna, Selda Yılmaz
(2024), pp. 103-117
Closed Access
